Darmiyan
PrivateLast Round
Seed
Oct 17, 2023
Est. Valuation
$52.04M
Total Funding Raised
$13.74M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Darmiyan is a health technology company that develops AI-powered brain imaging software platforms for the early detection, prognosis, and monitoring of neurodegenerative diseases like Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Darmiyan Comparables
Compare Darmiyan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Splink, Inc. | 81% | |
| Qynapse | 81% | |
| Brainreader | 80% |
Darmiyan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 17, 2023 | ||||
| Seed | Apr 10, 2020 | ||||
| Seed | Sep 29, 2017 | ||||
| Accelerator | Aug 19, 2017 | ||||
| Grant | Jul 11, 2017 |
Key People
Founding team and executive leadership
Darmiyan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IT-Farm Corporation | Seed |
| AAF Management | Seed |
| UpHonest Capital | Seed |
| Y Combinator | Seed, Accelerator |
| Soma Capital | Seed |
| Arkitekt Ventures | Seed |
| Centre for Aging and Brain Health Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 57% MoM.
- Jul 25, 2026
Monthly visitors grew 43% MoM.
Darmiyan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Darmiyan's valuation, stock price, and market status.
Is Darmiyan a public or private company?
Darmiyan is a private company.
What is the current stock price of Darmiyan?
Darmiyan is a private company with no public stock price. No recent secondary market data is available.
How much is Darmiyan worth (valuation)?
Darmiyan's valuation is estimated at $52.0M based on funding round data.
Can I buy Darmiyan stock?
Darmiyan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Darmiyan's last funding round?
Darmiyan's most recent funding round was Seed on October 4, 2023.
Who are the main investors in Darmiyan?
Key investors in Darmiyan include IT-Farm Corporation, Y Combinator.
Will Darmiyan IPO soon?
No public IPO plans have been announced for Darmiyan.
How can I track Darmiyan secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Darmiyan's secondary market activity and sign up for updates.